Donald A Bergstrom Relay Therapeutics, Inc. (RLAY) insider trading activity

Donald A Bergstrom is President, R&D of Relay Therapeutics, Inc.. Currently has a direct ownership of 521,823 shares of RLAY, which is worth approximately $3.45 Million. The most recent transaction as insider was on Apr 28, 2023, when has been sold 1,383 shares (Common Stock) at a price of $11.16 per share, resulting in proceeds of $15,434. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 522K

5.59% 3M change

0.33% 12M change

Total Value Held $3.45 Million

Donald A Bergstrom Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 28 2023	SELL Open market or private sale	$15,434 $11.16 p/Share	1,383 Reduced 0.57%	242,701 Common Stock
Mar 27 2023	SELL Open market or private sale	$11,719 $15.36 p/Share	763 Reduced 0.31%	244,084 Common Stock
Jan 30 2023	SELL Open market or private sale	$30,809 $21.56 p/Share	1,429 Reduced 0.58%	244,847 Common Stock
Jan 17 2023	BUY Grant, award, or other acquisition	-	160,390 Added 39.44%	246,276 Common Stock
Dec 27 2022	SELL Open market or private sale	$14,200 $14.49 p/Share	980 Reduced 1.13%	85,886 Common Stock
Nov 01 2022	SELL Open market or private sale	$182,000 $22.75 p/Share	8,000 Reduced 8.43%	86,866 Common Stock
Nov 01 2022	BUY Exercise of conversion of derivative security	$32,960 $4.12 p/Share	8,000 Added 7.78%	94,866 Common Stock

Oct 28 2022	SELL Open market or private sale	$39,138 $21.54 p/Share	1,817 Reduced 2.05%	86,866 Common Stock
Oct 03 2022	SELL Open market or private sale	$179,440 $22.43 p/Share	8,000 Reduced 8.27%	88,683 Common Stock
Oct 03 2022	BUY Exercise of conversion of derivative security	$32,960 $4.12 p/Share	8,000 Added 7.64%	96,683 Common Stock
Sep 27 2022	SELL Open market or private sale	$22,184 $22.73 p/Share	976 Reduced 1.09%	88,683 Common Stock
Sep 08 2022	SELL Open market or private sale	$750,000 $30.0 p/Share	25,000 Reduced 21.8%	89,659 Common Stock
Sep 08 2022	BUY Exercise of conversion of derivative security	$103,000 $4.12 p/Share	25,000 Added 17.9%	114,659 Common Stock
Sep 02 2022	SELL Open market or private sale	$124,754 $25.46 p/Share	4,900 Reduced 5.18%	89,659 Common Stock
Sep 02 2022	BUY Exercise of conversion of derivative security	$20,188 $4.12 p/Share	4,900 Added 4.93%	94,559 Common Stock
Sep 01 2022	SELL Open market or private sale	$186,867 $23.07 p/Share	8,100 Reduced 8.29%	89,659 Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	$33,372 $4.12 p/Share	8,100 Added 7.65%	97,759 Common Stock
Aug 24 2022	SELL Open market or private sale	$375,000 $25.0 p/Share	15,000 Reduced 14.33%	89,659 Common Stock
Aug 24 2022	BUY Exercise of conversion of derivative security	$61,800 $4.12 p/Share	15,000 Added 12.54%	104,659 Common Stock
Aug 05 2022	SELL Open market or private sale	$160,000 $20.0 p/Share	8,000 Reduced 8.19%	89,659 Common Stock
Aug 05 2022	BUY Exercise of conversion of derivative security	$32,960 $4.12 p/Share	8,000 Added 7.57%	97,659 Common Stock
Jul 28 2022	SELL Open market or private sale	$39,030 $21.27 p/Share	1,835 Reduced 2.01%	89,659 Common Stock
Jul 06 2022	SELL Open market or private sale	$160,000 $20.0 p/Share	8,000 Reduced 8.04%	91,494 Common Stock
Jul 06 2022	BUY Exercise of conversion of derivative security	$32,960 $4.12 p/Share	8,000 Added 7.44%	99,494 Common Stock
Jun 27 2022	SELL Open market or private sale	$20,290 $20.31 p/Share	999 Reduced 1.08%	91,494 Common Stock

Also insider at

FUSN

Fusion Pharmaceuticals Inc. Healthcare

DAB